CN Stock MarketDetailed Quotes

Brightgene Bio-Medical Technology Co.,Ltd. (688166)

Watchlist
  • 59.99
  • -1.19-1.95%
Market Closed Apr 24 15:00 CST
25.38BMarket Cap465.04P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Brightgene Bio-Medical Technology Co.,Ltd. (688166) Income Statement

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q9)Sep 30, 2025
(Q6)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
Total operating revenue
-4.59%1.22B
-10.50%874.25M
-18.28%537.44M
-26.81%248.96M
8.74%1.28B
6.77%976.83M
11.95%657.69M
11.54%340.13M
15.94%1.18B
18.46%914.88M
Operating revenue
-4.59%1.22B
-10.50%874.25M
-18.28%537.44M
-26.81%248.96M
8.74%1.28B
6.77%976.83M
11.95%657.69M
11.54%340.13M
15.94%1.18B
18.46%914.88M
Total operating cost
9.23%1.2B
7.68%859.67M
-0.84%549.54M
-0.29%266.56M
12.47%1.1B
14.11%798.34M
19.72%554.21M
16.64%267.34M
25.15%980.32M
23.89%699.6M
Operating cost
10.40%601.61M
3.58%424.93M
-6.24%275.67M
-4.22%139.55M
4.51%544.95M
8.26%410.24M
13.81%294.02M
16.19%145.69M
38.56%521.41M
30.85%378.94M
Operating tax surcharges
54.75%13.03M
75.77%8.9M
73.82%5.47M
70.50%2.69M
47.41%8.42M
14.60%5.07M
9.84%3.15M
12.95%1.58M
9.35%5.71M
33.21%4.42M
Operating expense
8.75%78.02M
9.83%61.77M
0.02%39.65M
17.65%17.43M
11.98%71.74M
24.69%56.24M
39.50%39.64M
-10.54%14.81M
-8.60%64.07M
-25.16%45.1M
Administration expense
11.06%154.51M
34.01%113.54M
26.80%70.73M
20.90%34.51M
19.53%139.12M
1.95%84.73M
7.66%55.78M
0.93%28.54M
1.31%116.4M
7.71%83.11M
Financial expense
27.66%52.23M
14.86%34.1M
4.63%19.74M
-7.88%10.75M
69.46%40.91M
22.61%29.69M
4.17%18.86M
30.84%11.67M
146.34%24.14M
613.79%24.21M
-Interest expense (Financial expense)
20.07%62.96M
22.20%48.37M
5.29%29.03M
7.60%14.97M
18.03%52.44M
17.92%39.58M
15.17%27.57M
30.15%13.91M
87.36%44.42M
214.91%33.57M
-Interest Income (Financial expense)
49.40%-5.55M
9.43%-7.96M
57.71%-2.97M
25.76%-1.14M
39.06%-10.96M
15.49%-8.79M
5.79%-7.01M
48.52%-1.54M
-703.62%-17.99M
-707.35%-10.4M
Research and development
2.52%304.95M
1.91%216.43M
-3.14%138.29M
-5.24%61.64M
19.65%297.45M
29.65%212.38M
38.09%142.76M
33.68%65.05M
20.08%248.59M
17.81%163.82M
Credit Impairment Loss
-64.12%-20.27M
143.12%3.13M
179.14%3.5M
-2,647.30%-3.2M
-400.68%-12.35M
-5.37%-7.25M
-16.91%-4.42M
-49.71%125.75K
-279.70%-2.47M
-146.30%-6.88M
Asset Impairment Loss
12.26%-17.5M
47.32%-2.76M
47.14%-2.77M
--708.01K
7.20%-19.94M
35.49%-5.23M
35.49%-5.23M
----
-46.70%-21.49M
-13.46%-8.11M
Other net revenue
Fair value change income
341.85%13.78M
49.93%1.51M
201.40%1.59M
169.44%1.72M
-996.09%-5.7M
295.29%1.01M
-189.76%-1.56M
-840.99%-2.48M
84.68%-520.01K
109.73%255.43K
Invest income
-66.08%-19.32M
-21.99%-11.75M
17.56%-5.43M
75.52%-1.11M
21.08%-11.63M
-16.96%-9.63M
-36.98%-6.58M
-192.83%-4.55M
-472.54%-14.74M
-189.46%-8.24M
-Including: Investment income associates
-37.72%-12.62M
-10.10%-7.88M
38.33%-3.02M
68.54%-1.07M
32.66%-9.16M
4.50%-7.16M
-5.48%-4.9M
-135.05%-3.41M
-52.58%-13.61M
-63.55%-7.5M
Asset deal income
----
----
----
----
----
----
----
----
--0
----
Other revenue
29.06%38.67M
64.60%18.06M
19.18%10.39M
58.11%7.59M
-1.00%29.97M
94.09%10.97M
120.71%8.72M
472.38%4.8M
45.12%30.27M
-28.85%5.65M
Operating profit
-90.85%14.66M
-86.47%22.77M
-105.11%-4.82M
-116.83%-11.9M
-15.75%160.29M
-14.96%168.35M
-16.86%94.4M
-6.50%70.69M
-21.44%190.24M
-6.72%197.96M
Add:Non operating Income
329.57%207.52K
408.53%178.43K
372.75%135.15K
1,474.08%99.45K
-75.73%48.31K
-81.97%35.09K
151.43%28.59K
358,861.36%6.32K
-81.06%199.02K
-81.93%194.61K
Less:Non operating expense
-69.31%962.81K
73.39%536.92K
179.56%334.25K
-39.71%66.97K
87.46%3.14M
-33.09%309.66K
-57.05%119.57K
--111.08K
67.50%1.67M
-41.68%462.78K
Total profit
-91.15%13.91M
-86.66%22.41M
-105.32%-5.02M
-116.81%-11.86M
-16.72%157.2M
-14.98%168.08M
-16.75%94.31M
-6.64%70.59M
-22.06%188.77M
-6.97%197.69M
Less:Income tax cost
-244.60%-23.05M
-142.08%-8.97M
-155.29%-6.68M
-182.11%-7.21M
3.85%15.94M
1.77%21.32M
-18.86%12.08M
-8.20%8.78M
-50.14%15.35M
-39.49%20.95M
Net profit
-73.84%36.95M
-78.61%31.39M
-97.98%1.66M
-107.53%-4.66M
-18.54%141.26M
-16.96%146.76M
-16.43%82.23M
-6.41%61.81M
-17.97%173.42M
-0.64%176.74M
Net profit from continuing operation
-73.84%36.95M
-78.61%31.39M
-97.98%1.66M
-107.53%-4.66M
-18.54%141.26M
-16.96%146.76M
-16.43%82.23M
-6.41%61.81M
-17.97%173.42M
-0.64%176.74M
Less:Minority Profit
63.34%-17.56M
38.23%-18.93M
35.72%-15.52M
-679.46%-17.62M
-64.94%-47.9M
-103.66%-30.65M
-118.42%-24.14M
52.17%-2.26M
-3.00%-29.04M
23.78%-15.05M
Net profit of parent company owners
-71.18%54.51M
-71.64%50.32M
-83.85%17.17M
-79.77%12.96M
-6.57%189.17M
-7.50%177.41M
-2.81%106.36M
-9.47%64.07M
-15.51%202.47M
-2.95%191.79M
Earning per share
Basic earning per share
-71.11%0.13
-71.43%0.12
-84.00%0.04
-80.00%0.03
-6.25%0.45
-6.67%0.42
-3.85%0.25
-11.76%0.15
-17.24%0.48
-6.25%0.45
Diluted earning per share
-71.11%0.13
-71.43%0.12
-84.00%0.04
-80.00%0.03
-6.25%0.45
-6.67%0.42
-3.85%0.25
-11.76%0.15
-17.24%0.48
-6.25%0.45
Other composite income
196.94%36.68M
92.64%-2.58M
92.66%-2.58M
96.93%-70.22K
-43.31%-37.83M
-614.69%-35.07M
-766.40%-35.14M
-2.29M
22.82%-26.4M
-2,417.43%-4.91M
Other composite income of parent company owners
196.94%36.68M
----
92.66%-2.58M
96.93%-70.22K
-43.31%-37.83M
----
-766.40%-35.14M
---2.29M
22.82%-26.4M
-2,417.43%-4.91M
Total composite income
-28.81%73.63M
-74.21%28.81M
-101.96%-922.64K
-107.94%-4.73M
-29.65%103.43M
-35.00%111.69M
-50.08%47.09M
-9.87%59.52M
-17.04%147.02M
-3.51%171.83M
Total composite income of parent company owners
-39.74%91.19M
-66.46%47.74M
-79.51%14.59M
-79.14%12.89M
-14.05%151.33M
-23.84%142.34M
-32.41%71.23M
-12.70%61.78M
-14.29%176.07M
-5.54%186.88M
Total composite income of minority owners
63.34%-17.56M
38.23%-18.93M
35.72%-15.52M
-679.46%-17.62M
-64.94%-47.9M
-103.66%-30.65M
-118.42%-24.14M
52.17%-2.26M
-3.00%-29.04M
23.78%-15.05M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
--
--
--
--
--
Unqualified opinion
--
Auditor
--
--
--
--
--
--
--
--
Notary Tianye Certified Public Accountants (Special General Partnership)
--
(FY)Dec 31, 2025(Q9)Sep 30, 2025(Q6)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023
Total operating revenue -4.59%1.22B-10.50%874.25M-18.28%537.44M-26.81%248.96M8.74%1.28B6.77%976.83M11.95%657.69M11.54%340.13M15.94%1.18B18.46%914.88M
Operating revenue -4.59%1.22B-10.50%874.25M-18.28%537.44M-26.81%248.96M8.74%1.28B6.77%976.83M11.95%657.69M11.54%340.13M15.94%1.18B18.46%914.88M
Total operating cost 9.23%1.2B7.68%859.67M-0.84%549.54M-0.29%266.56M12.47%1.1B14.11%798.34M19.72%554.21M16.64%267.34M25.15%980.32M23.89%699.6M
Operating cost 10.40%601.61M3.58%424.93M-6.24%275.67M-4.22%139.55M4.51%544.95M8.26%410.24M13.81%294.02M16.19%145.69M38.56%521.41M30.85%378.94M
Operating tax surcharges 54.75%13.03M75.77%8.9M73.82%5.47M70.50%2.69M47.41%8.42M14.60%5.07M9.84%3.15M12.95%1.58M9.35%5.71M33.21%4.42M
Operating expense 8.75%78.02M9.83%61.77M0.02%39.65M17.65%17.43M11.98%71.74M24.69%56.24M39.50%39.64M-10.54%14.81M-8.60%64.07M-25.16%45.1M
Administration expense 11.06%154.51M34.01%113.54M26.80%70.73M20.90%34.51M19.53%139.12M1.95%84.73M7.66%55.78M0.93%28.54M1.31%116.4M7.71%83.11M
Financial expense 27.66%52.23M14.86%34.1M4.63%19.74M-7.88%10.75M69.46%40.91M22.61%29.69M4.17%18.86M30.84%11.67M146.34%24.14M613.79%24.21M
-Interest expense (Financial expense) 20.07%62.96M22.20%48.37M5.29%29.03M7.60%14.97M18.03%52.44M17.92%39.58M15.17%27.57M30.15%13.91M87.36%44.42M214.91%33.57M
-Interest Income (Financial expense) 49.40%-5.55M9.43%-7.96M57.71%-2.97M25.76%-1.14M39.06%-10.96M15.49%-8.79M5.79%-7.01M48.52%-1.54M-703.62%-17.99M-707.35%-10.4M
Research and development 2.52%304.95M1.91%216.43M-3.14%138.29M-5.24%61.64M19.65%297.45M29.65%212.38M38.09%142.76M33.68%65.05M20.08%248.59M17.81%163.82M
Credit Impairment Loss -64.12%-20.27M143.12%3.13M179.14%3.5M-2,647.30%-3.2M-400.68%-12.35M-5.37%-7.25M-16.91%-4.42M-49.71%125.75K-279.70%-2.47M-146.30%-6.88M
Asset Impairment Loss 12.26%-17.5M47.32%-2.76M47.14%-2.77M--708.01K7.20%-19.94M35.49%-5.23M35.49%-5.23M-----46.70%-21.49M-13.46%-8.11M
Other net revenue
Fair value change income 341.85%13.78M49.93%1.51M201.40%1.59M169.44%1.72M-996.09%-5.7M295.29%1.01M-189.76%-1.56M-840.99%-2.48M84.68%-520.01K109.73%255.43K
Invest income -66.08%-19.32M-21.99%-11.75M17.56%-5.43M75.52%-1.11M21.08%-11.63M-16.96%-9.63M-36.98%-6.58M-192.83%-4.55M-472.54%-14.74M-189.46%-8.24M
-Including: Investment income associates -37.72%-12.62M-10.10%-7.88M38.33%-3.02M68.54%-1.07M32.66%-9.16M4.50%-7.16M-5.48%-4.9M-135.05%-3.41M-52.58%-13.61M-63.55%-7.5M
Asset deal income ----------------------------------0----
Other revenue 29.06%38.67M64.60%18.06M19.18%10.39M58.11%7.59M-1.00%29.97M94.09%10.97M120.71%8.72M472.38%4.8M45.12%30.27M-28.85%5.65M
Operating profit -90.85%14.66M-86.47%22.77M-105.11%-4.82M-116.83%-11.9M-15.75%160.29M-14.96%168.35M-16.86%94.4M-6.50%70.69M-21.44%190.24M-6.72%197.96M
Add:Non operating Income 329.57%207.52K408.53%178.43K372.75%135.15K1,474.08%99.45K-75.73%48.31K-81.97%35.09K151.43%28.59K358,861.36%6.32K-81.06%199.02K-81.93%194.61K
Less:Non operating expense -69.31%962.81K73.39%536.92K179.56%334.25K-39.71%66.97K87.46%3.14M-33.09%309.66K-57.05%119.57K--111.08K67.50%1.67M-41.68%462.78K
Total profit -91.15%13.91M-86.66%22.41M-105.32%-5.02M-116.81%-11.86M-16.72%157.2M-14.98%168.08M-16.75%94.31M-6.64%70.59M-22.06%188.77M-6.97%197.69M
Less:Income tax cost -244.60%-23.05M-142.08%-8.97M-155.29%-6.68M-182.11%-7.21M3.85%15.94M1.77%21.32M-18.86%12.08M-8.20%8.78M-50.14%15.35M-39.49%20.95M
Net profit -73.84%36.95M-78.61%31.39M-97.98%1.66M-107.53%-4.66M-18.54%141.26M-16.96%146.76M-16.43%82.23M-6.41%61.81M-17.97%173.42M-0.64%176.74M
Net profit from continuing operation -73.84%36.95M-78.61%31.39M-97.98%1.66M-107.53%-4.66M-18.54%141.26M-16.96%146.76M-16.43%82.23M-6.41%61.81M-17.97%173.42M-0.64%176.74M
Less:Minority Profit 63.34%-17.56M38.23%-18.93M35.72%-15.52M-679.46%-17.62M-64.94%-47.9M-103.66%-30.65M-118.42%-24.14M52.17%-2.26M-3.00%-29.04M23.78%-15.05M
Net profit of parent company owners -71.18%54.51M-71.64%50.32M-83.85%17.17M-79.77%12.96M-6.57%189.17M-7.50%177.41M-2.81%106.36M-9.47%64.07M-15.51%202.47M-2.95%191.79M
Earning per share
Basic earning per share -71.11%0.13-71.43%0.12-84.00%0.04-80.00%0.03-6.25%0.45-6.67%0.42-3.85%0.25-11.76%0.15-17.24%0.48-6.25%0.45
Diluted earning per share -71.11%0.13-71.43%0.12-84.00%0.04-80.00%0.03-6.25%0.45-6.67%0.42-3.85%0.25-11.76%0.15-17.24%0.48-6.25%0.45
Other composite income 196.94%36.68M92.64%-2.58M92.66%-2.58M96.93%-70.22K-43.31%-37.83M-614.69%-35.07M-766.40%-35.14M-2.29M22.82%-26.4M-2,417.43%-4.91M
Other composite income of parent company owners 196.94%36.68M----92.66%-2.58M96.93%-70.22K-43.31%-37.83M-----766.40%-35.14M---2.29M22.82%-26.4M-2,417.43%-4.91M
Total composite income -28.81%73.63M-74.21%28.81M-101.96%-922.64K-107.94%-4.73M-29.65%103.43M-35.00%111.69M-50.08%47.09M-9.87%59.52M-17.04%147.02M-3.51%171.83M
Total composite income of parent company owners -39.74%91.19M-66.46%47.74M-79.51%14.59M-79.14%12.89M-14.05%151.33M-23.84%142.34M-32.41%71.23M-12.70%61.78M-14.29%176.07M-5.54%186.88M
Total composite income of minority owners 63.34%-17.56M38.23%-18.93M35.72%-15.52M-679.46%-17.62M-64.94%-47.9M-103.66%-30.65M-118.42%-24.14M52.17%-2.26M-3.00%-29.04M23.78%-15.05M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----------------Unqualified opinion--
Auditor ----------------Notary Tianye Certified Public Accountants (Special General Partnership)--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +5.69%
Sample Name
Sample Code
 +0.44%
Sample Name
Sample Code
 -2.38%
4
CHINA OILFIELD
02883
-3.34%
5
CNOOC
00883
-5.23%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +30.01%
Sample Name
Sample Code
 +22.47%
Sample Name
Sample Code
 +20.53%
4
Rockchip Electronics
603893
+19.38%
5
Ucloud Technology Co., Ltd
688158
+18.90%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -